MaxLinear
MXL
$101.10
+5.18%
MaxLinear, Inc. is a semiconductor company specializing in the design of radio frequency and mixed-signal integrated circuits for broadband communications, including cable and satellite networks, connected home devices, and data center fiber optics. The company operates as a niche player in the competitive semiconductor industry, focusing on enabling high-speed data distribution and connectivity. The current investor narrative is overwhelmingly driven by the company's explosive growth tied to AI infrastructure, as evidenced by its stock's dramatic surge following a Q1 2026 earnings report that highlighted its role in the AI build-out, shifting its identity from a traditional broadband chip supplier to a potential high-growth beneficiary of AI-driven demand.…
MXL
MaxLinear
$101.10
Related headlines
Investment Opinion: Should I buy MXL Today?
Rating: Hold. The core thesis is that MXL represents a high-risk, binary bet on AI-driven growth where the extreme valuation and lack of current profitability fully offset the powerful momentum, making it unsuitable for new capital allocation except for speculative traders.
Supporting evidence for this cautious view includes: 1) A forward P/E of 53.1x that prices in heroic profit growth from a base of losses, 2) An EV/Sales ratio of 17.7x that implies sales must multiply rapidly, 3) A trailing net margin of -29.2% showing no margin of safety, and 4) A beta of 3.964 confirming extreme volatility that demands a risk premium. The stock's 749% annual gain is a testament to the narrative's power but also a warning of overextension.
The two biggest risks are the failure to achieve projected profitability (EPS of $2.04) and a broad de-rating of AI-related stocks. This Hold rating would upgrade to a Buy only if the company demonstrates sustained quarterly profitability and the forward P/E compresses below 30x on expanding earnings. It would downgrade to a Sell if revenue growth stalls or operating margins fail to improve, validating valuation concerns. Based on the available data, the stock is severely overvalued relative to its current financials, trading on narrative momentum alone.
Sign up to view all
MXL 12-Month Price Forecast
The AI assessment is neutral with medium confidence. While the AI narrative has fundamentally re-rated the stock, the current price appears to discount nearly perfect execution. The high probability base case involves volatile consolidation as reality is measured against sky-high expectations. The stance would upgrade to bullish only upon clear evidence of sustainable profitability and multiple expansion on rising earnings, not just revenue. It would downgrade to bearish if the next earnings report shows decelerating growth or widening losses, triggering a re-assessment of the entire growth story. The key is the upcoming quarter's ability to validate the Q1 surge as a trend, not an anomaly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MaxLinear's 12-month outlook, with a consensus price target around $131.43 and implied upside of +30.0% versus the current price.
Average Target
$131.43
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$81 - $131
Analyst target range
Analyst coverage for MaxLinear appears limited, with data showing only 4 analysts providing estimates for future EPS and revenue, but no consensus price target, recommendation, or Buy/Hold/Sell distribution is provided. The estimated EPS range for the next period is between $1.61 and $2.28, with an average of $2.04, and revenue estimates are tightly clustered around $869.5 million, indicating some consensus on the near-term financial outlook but a lack of formal price targets. The minimal analyst data suggests this is a stock with limited institutional research coverage, which can lead to higher volatility and less efficient price discovery, as seen in the extreme price moves; the absence of a consensus target price means investors must rely more heavily on their own fundamental and technical analysis to gauge fair value.
Bulls vs Bears: MXL Investment Factors
The bull case for MXL is compelling but extraordinarily speculative, built entirely on its recent re-rating as an AI infrastructure play, as evidenced by the 749% annual gain. The bear case, however, is grounded in concrete financial reality: the company is deeply unprofitable, trading at extreme valuations, and positioned for a potentially devastating correction from all-time highs. Currently, the bearish evidence from valuation and profitability metrics carries more weight than the bullish momentum narrative, as the stock price has far outpaced any fundamental improvement. The single most important tension in the investment debate is whether the explosive AI-driven revenue growth implied by the forward P/E of 53x can materialize quickly enough to bridge the vast chasm between current losses and future expectations before investor patience wears thin.
Bullish
- Parabolic AI-Driven Growth Narrative: The stock has surged +749.7% over the past year, with a +192.6% gain in the last month alone, driven by a Q1 2026 earnings report that repositioned the company as a key beneficiary of AI infrastructure build-out. This explosive price action reflects a powerful market re-rating based on a new, high-growth narrative.
- Strong Gross Margin & Pricing Power: The company maintains a robust gross margin of 56.8%, indicating solid pricing power and a favorable product mix within its semiconductor niche. This provides a strong foundation for future profitability as revenue scales and operating expenses are managed.
- Market Expects Rapid Profit Recovery: Despite a trailing net margin of -29.2%, the market is pricing in a swift turnaround with a forward P/E of 53.1x. Analyst consensus expects EPS to jump to an average of $2.04 for the next period, implying a significant shift from current losses to substantial profitability.
- Manageable Financial Leverage: The debt-to-equity ratio of 0.35 indicates a moderate and manageable level of financial leverage. Combined with a current ratio of 1.34, the balance sheet suggests adequate liquidity to fund operations without excessive risk from debt servicing.
Bearish
- Extreme Valuation & Profitability Disconnect: The stock trades at an EV/Sales of 17.72x and a forward P/E of 53.1x while being deeply unprofitable (trailing net margin -29.2%, ROE -30.2%). This valuation is exceptionally high and hinges entirely on flawless execution of the AI growth story to justify the premium.
- Catastrophic Downside Risk from Current Highs: Trading at 95% of its 52-week high ($99.16 vs. $104.27) after a parabolic move, the stock faces a severe risk of a sharp correction. A reversion to its 52-week low of $10.96 would represent an 89% loss from the current price, highlighting extreme volatility.
- Current Unprofitability & Negative Cash Flow: The company is burning cash, evidenced by a negative operating margin of -27.1% and a high Price-to-Cash Flow ratio of 76.9x. This raises sustainability concerns if the anticipated AI revenue ramp is delayed or fails to materialize as expected.
- Limited Analyst Coverage & High Volatility: With only 4 analysts providing estimates and no consensus price target, the stock suffers from less efficient price discovery. This, combined with a beta of 3.964 (nearly 300% more volatile than the market), makes it a high-risk, speculative instrument prone to exaggerated swings.
MXL Technical Analysis
The stock is in a parabolic, sustained uptrend, with a staggering 1-year price change of +749.7%. As of the latest close at $99.16, the stock is trading at approximately 95% of its 52-week high of $104.27, indicating extreme momentum and positioning it near its all-time highs, which suggests both powerful bullish sentiment and a heightened risk of overextension or a sharp correction. Recent momentum is exceptionally strong and accelerating, with a 1-month gain of +192.6% and a 3-month gain of +436.9%, far outpacing the broader market's performance (SPY +4.84% and +8.15% over the same periods); this massive short-term surge confirms and amplifies the longer-term uptrend, signaling a powerful, news-driven re-rating of the stock. Key technical support is at the 52-week low of $10.96, though a more relevant near-term level is likely the recent breakout zone around $60-$70, while immediate resistance is the 52-week high of $104.27; a beta of 3.964 indicates the stock is nearly 300% more volatile than the market, making it a high-risk, high-reward proposition where position sizing is critical.
Beta
3.96
3.96x market volatility
Max Drawdown
-26.8%
Largest decline past year
52-Week Range
$11-$106
Price range past year
Annual Return
+748.9%
Cumulative gain past year
| Period | MXL Return | S&P 500 |
|---|---|---|
| 1m | +95.7% | +4.9% |
| 3m | +464.2% | +8.9% |
| 6m | +549.3% | +9.8% |
| 1y | +748.9% | +26.9% |
| ytd | +446.2% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MXL Fundamental Analysis
Revenue and growth trajectory data from quarterly financials is not available in the provided dataset, preventing a detailed analysis of recent trends, segment drivers, or acceleration/deceleration. Profitability metrics show the company is currently unprofitable, with a trailing net margin of -29.2% and negative EPS of -$0.09, though the forward PE ratio of 53.1x suggests the market is pricing in a significant return to profitability; the gross margin of 56.8% is a strong positive, indicating solid pricing power and product mix, but this is offset by an operating margin of -27.1%, highlighting significant operating expenses relative to revenue. Balance sheet and cash flow health cannot be fully assessed due to missing cash flow statements and detailed ratio data; however, the available current ratio of 1.34 suggests adequate short-term liquidity, and a debt-to-equity ratio of 0.35 indicates a moderate, manageable level of financial leverage, though the negative ROE of -30.2% and ROA of -6.2% reflect the current period of unprofitability and inefficient use of assets.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MXL Overvalued?
Given the negative trailing Net Income and EPS, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 3.23x, while the Enterprise Value-to-Sales (EV/Sales) is significantly higher at 17.72x, reflecting the impact of debt and cash on the valuation; the forward PE of 53.1x, despite negative current earnings, underscores the market's expectation for a rapid and substantial profit recovery. Peer comparison data for industry averages is not available in the provided valuation dataset, making it impossible to quantify whether the PS or EV/Sales multiples represent a premium or discount to the semiconductor sector. Historical context for the stock's own valuation ratios is also unavailable, preventing an assessment of whether the current multiples are near the top or bottom of its historical range, which would help gauge if the market is pricing in overly optimistic or pessimistic expectations.
PE
-11.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-27.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe. The company is fundamentally unprofitable with a net margin of -29.2% and negative EPS, operating with a significant cash burn as indicated by a P/CF ratio of 76.9x. While debt is moderate (D/E 0.35), the negative ROE of -30.2% signals inefficient use of capital. The investment thesis is entirely dependent on a rapid and massive revenue acceleration tied to AI, creating binary success-or-failure risk; any stumble in this growth trajectory would immediately collapse the valuation.
Market & Competitive Risks are amplified by extreme valuation and volatility. Trading at an EV/Sales of 17.7x and a forward P/E of 53.1x, the stock is priced for perfection in a highly competitive semiconductor sector. A beta of 3.964 means it is nearly 300% more volatile than the market, making it acutely sensitive to sector-wide rotations away from growth or AI-themed stocks. The lack of analyst consensus targets suggests limited institutional anchoring, which can lead to disorderly, sentiment-driven price action, as seen in the recent parabolic move and subsequent choppy trading.
Worst-Case Scenario involves the AI growth narrative failing to materialize in upcoming quarters, leading to a collapse in sentiment. This could trigger a rapid de-rating from current premium multiples back towards its pre-hype valuation levels. A realistic downside scenario could see the stock retracing a significant portion of its gains, potentially falling towards the $60-$70 breakout zone (a -30% to -40% decline) or, in a full panic, testing its 52-week low of $10.96, which would represent a catastrophic loss of approximately 89% from the current price of $99.16. The recent max drawdown of -26.81% is a minor preview of this potential volatility.
FAQ
The key risks are, in order of severity: 1) Valuation & Profitability Risk: The stock could crash if it fails to achieve the profitability (EPS $2.04) implied by its 53x forward P/E. 2) Momentum Reversal Risk: After a 749% annual gain, any disappointment could trigger a violent correction; the 52-week low is 89% below the current price. 3) Operational Risk: The company is burning cash (negative operating margin) and must execute a complex product shift into AI. 4) Market Risk: With a beta of 3.964, it will fall 3-4 times harder than the market in a downturn, and limited analyst coverage exacerbates volatility.
The 12-month forecast for MXL is characterized by high uncertainty and a wide range of outcomes. The base case (50% probability) sees the stock consolidating between $70 and $90 as growth is validated but valuation compresses. The bull case (25% probability) could drive the stock to $120-$140 if AI revenue exceeds expectations. The bear case (25% probability) risks a collapse to $30-$50 if the growth narrative falters. The most likely scenario is the volatile base case, as the stock digests its massive gains and the market waits for concrete proof of sustained profitability.
MXL is severely overvalued based on its current financials. With a negative net margin of -29.2% and negative EPS, traditional P/E is meaningless, but the forward P/E of 53.1x and EV/Sales of 17.7x are exceptionally high multiples. This valuation implies the market expects a miraculous and rapid transformation to high profitability (EPS of $2.04). Compared to its own 52-week low of $10.96, the stock trades at a 9x premium, indicating it is priced for a near-perfect future with no margin of safety for error.
MXL is not a good stock to buy for most investors. It is a highly speculative, binary bet on unproven AI-driven growth, trading at extreme valuations (forward P/E 53x) while currently unprofitable. The potential upside, reflected in the bull case target of $140, is outweighed by the severe downside risk of a correction to $50 or lower, especially given its 3.964 beta. It might only be suitable for aggressive, short-term traders with high risk tolerance who can actively manage positions, not for long-term buy-and-hold investors seeking fundamental stability.
MXL is unsuitable for a traditional long-term investment due to its extreme volatility, lack of profitability, and binary narrative dependence. Its 3.964 beta and parabolic price move indicate it is a trading vehicle, not a stable compounder. It pays no dividend and offers no earnings visibility. A suggested minimum holding period does not apply; this is a stock for short-term, tactical trading by sophisticated investors who can monitor it daily. Any long-term holding would be a pure gamble on the AI thesis playing out perfectly over several years.